Prognostic Value of Kidney Function in Patients With ST-Elevation and Non-ST-Elevation Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention

American Journal of Kidney Diseases

Volumn 54, Issue 5, 2009, Pages 830-839

  Seyfarth, Melchior ^a   Kastrati, Adnan ^a   Mann, Johannes F E ^b   Ndrepepa, Gjin ^a   Byrne, Robert A ^a   Schulz, Stefanie ^a   Mehilli, Julinda ^a   Schömig, Albert ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Klinikum Schwabing   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

acute myocardial infarction; estimated creatinine clearance; Kidney function; landmark analysis; mortality

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; BLEEDING; CONTROL GROUP; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; CREATININE CLEARANCE; DEATH; DRUG ELUTING STENT; FEMALE; GERMANY; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PROGNOSIS; PROSPECTIVE STUDY; RISK; ST SEGMENT ELEVATION; STROKE; TREATMENT DURATION;

EID: 70350163255     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.04.031     Document Type: Article

References (32)

1. Schiffrin E.L., Lipman M.L., and Mann J.F. Chronic kidney disease: Effects on the cardiovascular system. Circulation 116 (2007) 85-97
2. Szczech L.A., Best P.J., Crowley E., et al. Outcomes of patients with chronic renal insufficiency in the Bypass Angioplasty Revascularization Investigation. Circulation 105 (2002) 2253-2258
3. Best P.J., Lennon R., Ting H.H., et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39 (2002) 1113-1119
4. Pinkau T., Mann J.F., Ndrepepa G., et al. Coronary revascularization in patients with renal insufficiency: Restenosis rate and cardiovascular outcomes. Am J Kidney Dis 44 (2004) 627-635
5. Al Suwaidi J., Reddan D.N., Williams K., et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 106 (2002) 974-980
6. Anavekar N.S., McMurray J.J.V., Velazquez E.J., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (2004) 1285-1295
7. Mielniczuk L.M., Pfeffer M.A., Lewis E.F., et al. Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome. Am Heart J 155 (2008) 725-731
8. Wright R.S., Reeder G.S., Herzog C.A., et al. Acute myocardial infarction and renal dysfunction: A high-risk combination. Ann Intern Med 137 (2002) 563-570
9. Herzog C.A., Ma J.Z., and Collins A.J. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 339 (1998) 799-805
10. Antman E.M., Hand M., Armstrong P.W., et al. 2007 Focused update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society Endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 117 (2008) 296-329
11. ACC/AHA. 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction): Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116 (2007) e148-e304
12. Shlipak M.G., Heidenreich P.A., Noguchi H., Chertow G.M., Browner W.S., and McClellan M.B. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137 (2002) 555-562
13. Keeley E.C., Kadakia R., Soman S., Borzak S., and McCullough P.A. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 92 (2003) 509-514
14. Gibson C.M., Dumaine R.L., Gelfand E.V., et al. Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; Observations in 13,307 patients in five TIMI trials. Eur Heart J 25 (2004) 1998-2005
15. Sadeghi H.M., Stone G.W., Grines C.L., et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 108 (2003) 2769-2775
16. Coca S.G., Krumholz H.M., Garg A.X., and Parikh C.R. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 296 (2006) 1377-1384
17. Mehta S.R., Yusuf S., Peters R.J.G., et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE Study. Lancet 358 (2001) 527-533
18. TIMI Study Group. Definitions Used in TIMI Trials. http://wwwtimiorg/ Accessed December 15, 2008
19. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
20. Grambsch P.M., and Therneau T.M. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81 (1994) 515-526
21. Keltai M., Tonelli M., Mann J.F., et al. Renal function and outcomes in acute coronary syndrome: Impact of clopidogrel. Eur J Cardiovasc Prev Rehabil 14 (2007) 312-318
22. Winkelmayer W.C., Charytan D.M., Brookhart M.A., Levin R., Solomon D.H., and Avorn J. Kidney function and use of recommended medications after myocardial infarction in elderly patients. Clin J Am Soc Nephrol 1 (2006) 796-801
23. Patel U.D., Ou F.S., Ohman E.M., et al. Hospital performance and differences by kidney function in the use of recommended therapies after non-ST-elevation acute coronary syndromes. Am J Kidney Dis 53 (2009) 426-437
24. Gibson C.M., Pinto D.S., Murphy S.A., et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol 42 (2003) 1535-1543
25. Best P.J.M., Steinhubl S.R., Berger P.B., et al. The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: Results from the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial. Am Heart J 155 (2008) 687-693
26. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis 39 suppl 1 (2002) S1-S266
27. Rihal C.S., Textor S.C., Grill D.E., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 (2002) 2259-2264
28. Ndrepepa G., Mehilli J., Schulz S., et al. Patterns of presentation and outcomes of patients with acute coronary syndromes. Cardiology 113 (2009) 198-206
29. de Lemos J.A., Blazing M.A., Wiviott S.D., et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial. JAMA 292 (2004) 1307-1316
30. Pfeffer M.A., McMurray J.J., Velazquez E.J., et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349 (2003) 1893-1906
31. Stevens L.A., Coresh J., Greene T., and Levey A.S. Assessing kidney function-Measured and estimated glomerular filtration rate. N Engl J Med 354 (2006) 2473-2483
32. Melloni C., Peterson E.D., Chen A.Y., et al. Cockcroft-Gault versus Modification of Diet in Renal Disease: Importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 51 (2008) 991-996